-
@ Layer3.news
2025-05-09 01:30:24
nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqvap2usgr7nawhqexfk247ap0nfs34jqpjrxqqslrkv3rrrx8aesst3mr8r
NOVO NORDISK PREDICTS STRONG SECOND HALF
https://s.yimg.com/ny/api/res/1.2/kxR1yYGqlL85ttFxviHVLA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/c8d4ca7f00eaa783c0d67491e8c43499
--
✍️ Novo Nordisk reported an earnings beat, but sales fell short of expectations, despite strong business results and an upbeat outlook for the rest of the year.
--
👉 Novo Nordisk reported an earnings beat, but sales fell short of expectations
👉 Diabetes and obesity care sales grew by 19%
👉 Management gave an encouraging outlook for the rest of the year
👉 CEO Lars Fruergaard Jorgensen attributed the strong results to efforts to prevent compounding and expand patient access
--
#LarsFruergaardJorgensen #business
--
nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqlst593t7qu54h30qnmguadcldvytrqa9jt2akz7mflkdgw5qlakslp8m9e